Triclosan
FDA-approved product (paste, dental).
- Registered studies
- 50+
- Lab records
- 8
- Pathogens at ≥40%
- 4 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLNo approved indication recorded
ChEMBL records no approved indication for Triclosan. Its therapeutic class is shown instead.
- WHO therapeutic group
- Phenol and derivatives; Medicated dressings with antiinfectives
- Anti-infective classification
- Classified as another kind of anti-infective (for example an antifungal, antiviral or antiparasitic medicine).WHO ATC D08AE04; WHO ATC D09AA06
Repurposing investigation
This medicine is being investigated here for AI-predicted antimicrobial activity against E. coli, MRSA, K. pneumoniae and M. tuberculosis. It was surfaced computationally for further investigation; it is not an established treatment for these infections.
AI-predicted activity
AI prediction · nothing measured- MRSA64.9% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates. This medicine was in the model's training data, so this is recall, not a new prediction.
- E. coli81.0% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates. This medicine was in the model's training data, so this is recall, not a new prediction.
- K. pneumoniae68.0% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates. This medicine was in the model's training data, so this is recall, not a new prediction.
- M. tuberculosis84.2% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates. This medicine was in the model's training data, so this is recall, not a new prediction.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
- MRSA: measured active in 2 of 2 lab records
- E. coli: measured active in 2 of 2 lab records
- K. pneumoniae: measured active in 1 of 2 lab records
- M. tuberculosis: measured active in 2 of 2 lab records
Show the 8 laboratory records, with sources
Loading records…
“Active” means the measured value reached this project’s laboratory cutoff (10 µM or stronger). A laboratory result does not show an effect in patients.
Docking
Computational · nothing measuredAutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Triclosan with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Goserelin AcetateExisting use: Breast cancer, Breast carcinoma, Carcinoma and 1 more58.5% AI-predicted activityagainst E. coli50+ registered studies
- Doxazosin MesylateExisting use: Benign prostatic hyperplasia, Hypertension, Myocardial infarction58.3% AI-predicted activityagainst E. coli50+ registered studies
- Chlorhexidine GluconateExisting use: Eye infection, Gingivitis, Infection and 2 more58.1% AI-predicted activityagainst E. coliLab records exist50+ registered studies
- Zavegepant HydrochlorideExisting use: Migraine disorder57.8% AI-predicted activityagainst E. coliNo documented evidence found
- Bremelanotide AcetateExisting use: Mental or behavioural disorder, Physiological sexual disorder, Sexual dysfunction57.4% AI-predicted activityagainst E. coli1 registered study
- Trametinib Dimethyl SulfoxideExisting use: Cancer, Cutaneous melanoma, Glioblastoma multiforme and 5 more57.2% AI-predicted activityagainst E. coli16 registered studies
- Degarelix AcetateExisting use: Prostate adenocarcinoma, Prostate cancer, Prostate carcinoma57.2% AI-predicted activityagainst E. coli50+ registered studies
- Cisapride MonohydrateExisting use: Gastrointestinal disease56.3% AI-predicted activityagainst E. coli5 registered studies
- Prazosin HydrochlorideExisting use: Diabetes mellitus, Hypertension56.3% AI-predicted activityagainst E. coli50+ registered studies
- PemigatinibExisting use: Cancer, Cholangiocarcinoma, Neoplasm56.0% AI-predicted activityagainst E. coli50+ registered studies
- AtogepantExisting use: Migraine disorder56.0% AI-predicted activityagainst E. coli36 registered studies
- Dolutegravir SodiumExisting use: HIV infection, HIV-1 infection55.9% AI-predicted activityagainst E. coli50+ registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Intervascular Post-Market Clinical Follow-Up (PMCF) Registry
NCT07322913 · start 2025-12-19
Registered record
- Registry ID
- NCT07322913
- Conditions
- Carotid Artery Diseases; Aortic Diseases; Peripheral Arterial Diseases
- Interventions
- Intergard Standard - Collagen Coated Vascular Grafts and Patches; Hemashield - Collagen Coated Vascular Grafts and Patches; Intergard Silver - Antimicrobial Collagen Coated Vascular Grafts and Patches; Intergard Synergy - Antimicrobial Collagen Coated Vascular Grafts
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Recruiting
- Start
- 2025-12-19
- Completion
- 2027-07
- Enrolment
- 1,200
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCarotid Artery Diseases; Aortic Diseases; Peripheral Arterial DiseasesInterventionIntergard Standard - Collagen Coated Vascular Grafts and Patches; Hemashield - Collagen Coated Vascular Grafts and Patches; Intergard Silver - Antimicrobial Collagen Coated Vascular Grafts and Patches; Intergard Synergy - Antimicrobial Collagen Coated Vascular GraftsPhaseNot recordedRegistry statusRecruitingSoft Tissue Healing and Bacterial Load With Triclosan-Coated Sutures After Impacted Mandibular Third Molar Surgery
NCT07386366 · start 2025-10-07
Registered record
- Registry ID
- NCT07386366
- Conditions
- Impacted Mandibular Third Molar; Postoperative Wound Healing
- Interventions
- Triclosan-coated Polyglactin 910 suture; Non-coated polyglactin 910 suture
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2025-10-07
- Completion
- 2026-03-31
- Enrolment
- 15
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionImpacted Mandibular Third Molar; Postoperative Wound HealingInterventionTriclosan-coated Polyglactin 910 suture; Non-coated polyglactin 910 suturePhaseNot applicableRegistry statusCompletedBarbed Suture vs Non-Barbed Closure for Emergency Exploratory Laparotomy RCT
NCT06043414 · start 2024-01-01
Registered record
- Registry ID
- NCT06043414
- Conditions
- Laparotomy; Dehiscence Wound; Surgical Site Infections; Trauma Abdomen; Emergency General Surgery
- Interventions
- triclosan-coated barbed suture; triclosan-coated non-barbed suture; Non-coated non-barbed suture
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Not yet recruiting
- Start
- 2024-01-01
- Completion
- 2027-01-31
- Enrolment
- 250
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionLaparotomy; Dehiscence Wound; Surgical Site Infections; Trauma Abdomen +1 moreInterventiontriclosan-coated barbed suture; triclosan-coated non-barbed suture; Non-coated non-barbed suturePhaseNot applicableRegistry statusNot yet recruitingStudy to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of Scalp
NCT05105139 · start 2021-11-29
Registered record
- Registry ID
- NCT05105139
- Conditions
- Seborrheic Dermatitis; Psoriasis of Scalp
- Interventions
- Allantoin/ Coal Tar/ Clioquinol; Allantoin/ Coal Tar/ Clioquinol/ Triclosan
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2021-11-29
- Completion
- 2022-02-25
- Enrolment
- 90
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSeborrheic Dermatitis; Psoriasis of ScalpInterventionAllantoin/ Coal Tar/ Clioquinol; Allantoin/ Coal Tar/ Clioquinol/ TriclosanPhaseNot recordedRegistry statusCompletedTriclosan-antibacterial Sutures Impact on the Incidence of Surgical Site Infection in Laparoscopic Surgeries.
NCT04255927 · start 2020-02-05
Registered record
- Registry ID
- NCT04255927
- Conditions
- Laparoscopic Surgery; Surgical Wound; Surgical Site Infection
- Interventions
- Coated Vicryl plus; Coated vicryl
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2020-02-05
- Completion
- 2022-04-20
- Enrolment
- 912
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionLaparoscopic Surgery; Surgical Wound; Surgical Site InfectionInterventionCoated Vicryl plus; Coated vicrylPhasePhase 4Registry statusCompletedTriclosan-antibacterial Sutures Efficacy on the Incidence of Surgical Site Infection in Clean-contaminated Wounds
NCT04256824 · start 2020-02-05
Registered record
- Registry ID
- NCT04256824
- Conditions
- Surgical Site Infection; Surgical Wound; Surgical Wound Infection
- Interventions
- coated vicryl plus; Vicryl
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Unknown
- Start
- 2020-02-05
- Completion
- 2024-01-30
- Enrolment
- 430
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSurgical Site Infection; Surgical Wound; Surgical Wound InfectionInterventioncoated vicryl plus; VicrylPhasePhase 4Registry statusUnknownA Study of Two Types of Absorbable Surgical Sutures in the Suturing of Thyroid Surgery Incision
NCT03792737 · start 2019-04-01
Registered record
- Registry ID
- NCT03792737
- Conditions
- Sutures
- Interventions
- Spiral PDS Plus; Spiral MONOCRYL Plus; PDS Plus; MONOCRYL Plus; VICRYL Plus
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2019-04-01
- Completion
- 2020-01-06
- Enrolment
- 501
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSuturesInterventionSpiral PDS Plus; Spiral MONOCRYL Plus; PDS Plus; MONOCRYL Plus +1 morePhaseNot applicableRegistry statusCompletedEffect of Barbed Suture and Triclosan-coated Monofilament in Emergency Surgery
NCT03763279 · start 2018-11-30
Registered record
- Registry ID
- NCT03763279
- Conditions
- Surgical Site Infection
- Interventions
- Triclosan-coated barbed suture; Triclosan-coated monofilament suture; Monofilament suture
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2018-11-30
- Completion
- 2019-03-31
- Enrolment
- 150
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSurgical Site InfectionInterventionTriclosan-coated barbed suture; Triclosan-coated monofilament suture; Monofilament suturePhasePhase 3Registry statusCompletedFALCON Trial Testing Measures to Reduce Surgical Site Infection
NCT03700749 · start 2018-11-29
Registered record
- Registry ID
- NCT03700749
- Conditions
- Abdominal Surgery; Surgical Site Infection
- Interventions
- 2% chlorhexidine + non-coated suture; 2% chlorhexidine + coated suture; 10%povidone-iodine + non-coated suture; 10%povidone-iodine + coated suture
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Unknown
- Start
- 2018-11-29
- Completion
- 2021-07-31
- Enrolment
- 5,480
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAbdominal Surgery; Surgical Site InfectionIntervention2% chlorhexidine + non-coated suture; 2% chlorhexidine + coated suture; 10%povidone-iodine + non-coated suture; 10%povidone-iodine + coated suturePhasePhase 3Registry statusUnknownMeta-analysis of Stannous Fluoride and the Effects on Dental Plaque
NCT04006483 · start 2018-01-08
Registered record
- Registry ID
- NCT04006483
- Conditions
- Dental Plaque
- Interventions
- Stannous fluoride dentifrice; Positive control dentifrice; Negative control dentifrice
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2018-01-08
- Completion
- 2018-11-30
- Enrolment
- 2,359
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionDental PlaqueInterventionStannous fluoride dentifrice; Positive control dentifrice; Negative control dentifricePhaseNot recordedRegistry statusCompletedEffect of a Combination of Bundles on Surgical-site Infection After Elective Colorectal Surgery
NCT03081962 · start 2017-02-15
Registered record
- Registry ID
- NCT03081962
- Conditions
- Surgical Site Infection
- Interventions
- Bundle; Standard care
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Unknown
- Start
- 2017-02-15
- Completion
- 2017-08
- Enrolment
- 102
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSurgical Site InfectionInterventionBundle; Standard carePhasePhase 3Registry statusUnknownEfficacy of Triclosan-coated Sutures in the Episiotomy
NCT02847936 · start 2016-07
Registered record
- Registry ID
- NCT02847936
- Conditions
- Episiotomy
- Interventions
- vicryl plus suture; vicryl suture
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Unknown
- Start
- 2016-07
- Completion
- 2016-09
- Enrolment
- 400
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionEpisiotomyInterventionvicryl plus suture; vicryl suturePhasePhase 4Registry statusUnknownTriclosan as Adjunctive Therapy in the Plaque Control in Children From Generalized Aggressive Periodontitis Families.
NCT03642353 · start 2016-01-30
Registered record
- Registry ID
- NCT03642353
- Conditions
- Generalized Aggressive Periodontitis
- Interventions
- Triclosan; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2016-01-30
- Completion
- 2016-12-20
- Enrolment
- 40
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionGeneralized Aggressive PeriodontitisInterventionTriclosan; PlaceboPhasePhase 4Registry statusCompletedClinical Investigation of the Effects of Colgate Total Toothpaste as Compared to a Matching Placebo on Periodontal Disease and Systemic Inflammatory Markers
NCT02670135 · start 2015-06
Registered record
- Registry ID
- NCT02670135
- Conditions
- Periodontal Disease; Systemic Inflammatory Markers
- Interventions
- Triclosan Containing Toothpaste; Triclosan Free Toothpaste
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2015-06
- Completion
- 2016-08
- Enrolment
- 303
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPeriodontal Disease; Systemic Inflammatory MarkersInterventionTriclosan Containing Toothpaste; Triclosan Free ToothpastePhasePhase 4Registry statusCompletedThe Clinical Investigation of a Zinc Based Toothpaste in Reducing Plaque and Gingivitis
NCT02243046 · start 2014-12
Registered record
- Registry ID
- NCT02243046
- Conditions
- Dental Plaque and Gingivitis
- Interventions
- Control toothpaste; Experimental toothpaste; Active Comparator
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2014-12
- Completion
- 2015-05
- Enrolment
- 162
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionDental Plaque and GingivitisInterventionControl toothpaste; Experimental toothpaste; Active ComparatorPhasePhase 2Registry statusCompleted